Physician profile
Christopher Chen
NPI 1740371152
$1,145.70
in general payments reported to CMS, 2019-2025
14 companies · $754 in 2025
The $754 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $67.33 · 2022: $52.41 · 2023: $36.58 · 2024: $236 · 2025: $754.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $526 · Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $526.27 |
| Food and Beverage | $499.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $616.09 | 2020-2025 | Amvia Edge |
| Coherus Oncology, INC. | $94.50 | 2022-2024 | |
| Astrazeneca Pharmaceuticals Lp | $85.58 | 2024-2025 | Wainua, Farxiga |
| Atricure, INC. | $82.07 | 2024-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Telix Pharmaceuticals | $61.22 | 2024-2025 | Illuccix |
| Integra Lifesciences Corporation | $36.07 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Cardiva Medical, INC. | $27.57 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Blueprint Medicines Corporation | $26.05 | 2025 | Ayvakit |
| Dendreon Pharmaceuticals LLC | $23.16 | 2024 | Provenge |
| Mirati Therapeutics, INC. | $20.76 | 2023 | Krazati |
| Boston Scientific Corporation | $20.30 | 2022 | |
| Stryker Corporation | $19.83 | 2025 | Inspace, Iconix |
| Adc Therapeutics America, INC. | $19.63 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $12.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.